CURLD (Curaleaf Holdings) Moat Score: 6/10 (As of Jun. 24, 2026)


CURLD Curaleaf Holdings Inc CURLD
67 GF Score
Price $9.33
GF Value $8.11
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Curaleaf Holdings Moat Score?

Curaleaf Holdings CURLD -1.48% 67 Moat Score is 6 as of Jun. 24, 2026. GuruFocus rates CURLD with a GF Score™ of 67/100 and a GF Value™ of $8.11 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 1,033 Drug Manufacturers companies, Curaleaf Holdings ranks better than 97.1% on this metric.

Curaleaf Holdings has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Curaleaf Holdings has Narrow Moat: Curaleaf Holdings Inc has a strong narrow moat due to its leading position in the cannabis industry, brand strength, and regulatory barriers. The company benefits from economies of scale and a broad distribution network. However, the industry is competitive and lacks significant customer switching costs or exclusive intellectual property.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Curaleaf Holdings might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Curaleaf Holdings  (OTCPK:CURLD) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Curaleaf Holdings Moat Score Related Terms

CURLD vs ZTS: Moat Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curaleaf Holdings's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curaleaf Holdings Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curaleaf Holdings's Moat Score distribution charts can be found below:

* The bar in red indicates where Curaleaf Holdings's Moat Score falls into.


CURLD
67GF Score
Curaleaf Holdings Inc CURLD
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 6 mean?
Curaleaf Holdings (CURLD) has a Moat Score of 6 as of Jun. 24, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Curaleaf Holdings ranks #30 out of 1033 companies in the Drug Manufacturers industry, placing it in the top 2.9%.
Is Curaleaf Holdings' Moat Score too high?
Curaleaf Holdings' current Moat Score is 6. Based on the distribution chart, Curaleaf Holdings ranks #30 out of 1033 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Curaleaf Holdings has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Curaleaf Holdings' Moat Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Curaleaf Holdings ranks #30 out of 1033 companies for Moat Score. This places Curaleaf Holdings in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Curaleaf Holdings's current Moat Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curaleaf Holdings stock overvalued right now?
Based on GuruFocus' analysis, Curaleaf Holdings (CURLD) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.11, compared to a current price of $9.33 — trading 15% above its estimated fair value. The current Moat Score is 6. Curaleaf Holdings' overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Curaleaf Holdings (CURLD), the current Moat Score is 6 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Curaleaf Holdings (CURLD) Overvalued in 2026?

Based on GuruFocus' analysis, Curaleaf Holdings stock appears to be overvalued. The current stock price of $9.33 is trading 15% above its estimated GF Value™ of $8.11. GuruFocus considers Curaleaf Holdings to be Modestly Overvalued.

Key valuation signals for CURLD:

  • Moat Score: 6
  • GF Value™: $8.11 vs. price of $9.33 (15% above fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the CURLD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Curaleaf Holdings Business Description

Other Exchanges 2XW:GermanyCURA:Canada
Address 290 Harbor Drive, Stamford, CT, USA, 06902
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
67GF Score

Get the complete analysis for CURLD

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.33
Price
$8.11
GF Value